Invention Grant
- Patent Title: Crk—a novel target for cancer therapy
-
Application No.: US15062941Application Date: 2016-03-07
-
Publication No.: US09606107B2Publication Date: 2017-03-28
- Inventor: Sasha Shafikhani
- Applicant: Rush University Medical Center
- Applicant Address: US IL Chicago
- Assignee: Rush University Medical Center
- Current Assignee: Rush University Medical Center
- Current Assignee Address: US IL Chicago
- Agency: McDermott Will & Emery LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/50 ; A61K38/18 ; A61K38/21 ; C12N5/02
Abstract:
The invention features a method of identifying a therapeutically active compound that inhibits apoptotic compensatory signaling complex (ACSC)-induced cell proliferation.
Public/Granted literature
- US20160258932A1 CRK - A NOVEL TARGET FOR CANCER THERAPY Public/Granted day:2016-09-08
Information query
